Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,121 | -11,990 | -4,146 | -1,693 | -4,316 |
| Depreciation Amortization | 11 | 7 | 5 | 3 | 9 |
| Accounts payable and accrued liabilities | -220 | -839 | 89 | -725 | N/A |
| Other Working Capital | -1,505 | -247 | 29 | -1,087 | 1,226 |
| Other Operating Activity | 3,969 | 2,216 | 706 | 1,366 | 0 |
| Operating Cash Flow | $-19,866 | $-10,853 | $-3,317 | $-2,136 | $-3,081 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -56 | -5 | -15 | -9 | 0 |
| Investing Cash Flow | $-56 | $-5 | $-15 | $-9 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,088 | 3,088 | 3,000 | 3,000 | N/A |
| Common Stock Issued | 221,191 | 640 | N/A | N/A | N/A |
| Other Financing Activity | 134,124 | 134,886 | 50,740 | 26,986 | 0 |
| Financing Cash Flow | $358,403 | $138,614 | $53,740 | $29,986 | $0 |
| Beginning Cash Position | 68 | 68 | 68 | 68 | 3,149 |
| End Cash Position | 338,549 | 127,824 | 50,476 | 27,909 | 68 |
| Net Cash Flow | $338,481 | $127,756 | $50,408 | $27,841 | $-3,081 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,866 | -10,853 | -3,317 | -2,136 | -3,081 |
| Capital Expenditure | -56 | -5 | -15 | -9 | N/A |
| Free Cash Flow | -19,922 | -10,858 | -3,332 | -2,145 | -3,081 |